Back to Journals » ClinicoEconomics and Outcomes Research » Volume 5

Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US

Total article views   Abstract views HTML views PDF downloads Totals
6,453 Dovepress* 4,367 237+ 1,254 4,604
PubMed Central* 0 1,849 670 1,849
Totals 4,367 2,086 1,924 6,453
*Since 2 September 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 4 4

View citations on PubMed Central and Google Scholar